Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Highlights of this issue

Highlights of this issue

CMAJ November 25, 2003 169 (11) 1141;
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Fetal alcohol spectrum disorder

Figure

Figure. Photo by: Anson Liaw

Fetal alcohol syndrome is defined by the classic triad of intrauterine and postnatal growth retardation, specific facial anomalies and adverse brain effects (mainly mental retardation). However, the triad occurs infrequently, and it is now appreciated that a spectrum of clinical problems, both physical and neurobehavioural, stems from alcohol exposure in utero. Koren and colleagues review the range of clinical problems in fetal alcohol spectrum disorder. They also provide information regarding screening questionnaires for diagnosing problem drinking, counselling of women during pregnancy and a novel laboratory test that uses neonatal meconium to detect evidence of maternal drinking.

See page 1181

Cholesterol-lowering drugs after coronary revascularization

Figure

Figure.

Hypercholesterolemia is a well-established risk factor for coronary atherosclerosis. Although cholesterol-lowering drugs are strongly recommended to modify this risk factor, and may even offer additional benefits such as improving endothelial function and enhancing plaque stability, it is unknown whether physicians and patients follow this recommendation. Brophy and colleagues report on the rate at which almost 12 000 patients filled at least one prescription for cholesterol-lowering drugs after coronary revascularization. After a mean follow-up of 3 years, they found that 37.2% of the patients had not had a single prescription filled. They also found that patients whose initial revascularization procedure was coronary artery bypass grafting were less likely than those who initially underwent angioplasty to have the prescription filled (odds ratio 0.77, 95% confidence interval 0.73–0.81). The authors suggest that continuity of care plays a crucial role in assuring long-term adherence to treatment in this group of patients.

See page 1153

Rehabilitation medicine: spasticity

Figure

Figure. Photo by: Christine Kenney

In the final article of CMAJ's series on rehabilitation medicine, Satkunam reviews the problem of spasticity in adults who have sustained an insult to the central nervous system. The pathophysiology of spasticity centres on the stretch reflex arc, comprised of muscle fibres and sensory and motor neurons. However, we are reminded that any noxious stimuli can increase the severity of the problem. The author outlines the practical approach to the management of patients with spasticity, including the clinical evaluation and various treatment options.

See page 1173

Antiviral therapy for SARS

Although physicians are accustomed to having a vast armamentarium of pharmacologic choices in normal practice, those who treated cases of severe acute respiratory syndrome (SARS) this past year were confronted with a disease for which there was no clear treatment. Some reports showed that ribavirin and steroids were of some help, whereas others showed that such treatment had no effect on clinical outcomes. From a unique perspective as the editor-in-chief of the China Medical Tribune, Zhaori discusses our experience to date with antiviral therapy in the treatment of SARS.

See page 1165

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 169 (11)
CMAJ
Vol. 169, Issue 11
25 Nov 2003
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of this issue
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of this issue
CMAJ Nov 2003, 169 (11) 1141;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Highlights of this issue
CMAJ Nov 2003, 169 (11) 1141;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Fetal alcohol spectrum disorder
    • Cholesterol-lowering drugs after coronary revascularization
    • Rehabilitation medicine: spasticity
    • Antiviral therapy for SARS
  • Responses
  • Metrics
  • PDF

Related Articles

  • Fetal alcohol spectrum disorder
  • The use of cholesterol-lowering medications after coronary revascularization
  • Rehabilitation medicine: 3. Management of adult spasticity
  • Antiviral treatment of SARS: Can we draw any conclusions?
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Highlights
  • Highlights
  • Highlights of this issue
Show more Highlights of this issue

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire